
HDFC Bank: Buy or sell? Brokerages maintain bullish view, see up to 18% upside on margin stability and long-term loan growth
Top brokerages remain bullish on HDFC Bank, reaffirming Buy ratings after the private lender reported a steady Q1FY26 performance. While net interest margins (NIM) compressed more than expected and slippages ticked up marginally, analysts point to strong provisioning, resilient core profitability, and a roadmap for loan growth revival as reasons to stay constructive on the stock. Nomura – Buy | Target: ₹2,190 | Upside: 12%
Nomura described the June quarter as a steady operating performance, with some softness on asset quality. However, the brokerage expects loan growth to pick up going forward, and sees the bank delivering RoA of 1.7–1.9% and RoE of 13–14.5% over FY26–28F. It values the core bank at 2.3x Jun-27F BVPS, maintaining a confident long-term view. Nuvama – Buy | Target: ₹2,270 | Upside: 16%
Nuvama highlighted a sharp 19 basis point QoQ drop in reported NIM, more than expected, but noted that core NIM declined only 11bps, reflecting underlying resilience. HDFC Bank reprices its EBLR (External Benchmark Linked Rate) loans faster than peers, affecting near-term margins.
The bank's asset quality remained best-in-class, with higher slippages primarily due to seasonal farm stress. Importantly, HDFC utilised nearly its entire ₹91 billion gain from HDB Financial Services for contingency and floating provisions, recognising just ₹8 billion as net gains—showcasing prudence in capital management. Core NII and PPOP were flat QoQ and up YoY, indicating operational stability. Bernstein – Buy | Target: ₹2,300 | Upside: 18%
Bernstein called it a good set of numbers, with headline EPS up 11% YoY. After adjusting for one-offs like the HDB stake sale, floating provisions, and tax credits, EPS growth stood at 7% YoY. Bernstein highlighted the loan-to-deposit ratio (LDR) falling to 95%, which positions the bank well to repair its balance sheet and resume healthy loan growth from FY27E. The brokerage continues to back HDFC Bank's long-term potential. Brokerage Summary: Brokerage Rating Target Price (₹) Upside from CMP (₹1,956) Bernstein Buy 2,300 +18% Nuvama Buy 2,270 +16% Nomura Buy 2,190 +12%
Despite near-term margin pressures, brokerages believe HDFC Bank's strong provisioning, capital discipline, and improving loan-to-deposit metrics will support sustainable growth over the next few years. All three firms remain firmly on the buy side, citing a favourable risk-reward at current levels.
Disclaimer: The brokerage views expressed are based on publicly available research reports and do not constitute investment advice. Readers should consult a certified financial advisor before making any investment decisions.
Ahmedabad Plane Crash
News desk at BusinessUpturn.com

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
14 hours ago
- Business Insider
Nomura Sticks to Its Buy Rating for Dr. Reddy's Laboratories Ltd. (DRREDDY)
In a report released on July 25, Saion Mukherjee from Nomura maintained a Buy rating on Dr. Reddy's Laboratories Ltd., with a price target of INR1,660.00. The company's shares closed last Friday at INR1,277.90. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Mukherjee covers the Healthcare sector, focusing on stocks such as Alkem Laboratories Ltd., Cipla Ltd, and Dr. Reddy's Laboratories Ltd.. According to TipRanks, Mukherjee has an average return of 15.0% and a 75.00% success rate on recommended stocks. Currently, the analyst consensus on Dr. Reddy's Laboratories Ltd. is a Hold with an average price target of INR1,236.44, representing a -3.24% downside. In a report released on July 25, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a INR1,416.00 price target. Based on Dr. Reddy's Laboratories Ltd.'s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of INR85.06 billion and a net profit of INR15.94 billion. In comparison, last year the company earned a revenue of INR70.83 billion and had a net profit of INR13.07 billion


Business Insider
14 hours ago
- Business Insider
Bernstein Sticks to Their Hold Rating for DKSH Holding AG (DKSH)
Bernstein analyst Alex Irving maintained a Hold rating on DKSH Holding AG on July 25. The company's shares closed last Friday at CHF58.70. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Irving covers the Industrials sector, focusing on stocks such as EasyJet, International Consolidated Airlines, and Deutsche Lufthansa. According to TipRanks, Irving has an average return of 9.4% and a 61.16% success rate on recommended stocks. In addition to Bernstein, DKSH Holding AG also received a Hold from TR | OpenAI – 4o's Fiona Plannesse in a report issued on July 18. However, on July 17, Berenberg Bank maintained a Buy rating on DKSH Holding AG (Six Swiss: DKSH).


Business Insider
2 days ago
- Business Insider
Bernstein Sticks to Their Sell Rating for Bajaj Finance Limited (BAJFINANCE)
In a report released today, Pranav Dheeeraj Gundlapalle from Bernstein maintained a Sell rating on Bajaj Finance Limited, with a price target of INR640.00. The company's shares closed today at INR913.75. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Dheeeraj Gundlapalle is a 3-star analyst with an average return of 9.2% and a 63.64% success rate. In addition to Bernstein, Bajaj Finance Limited also received a Sell from UBS's Alok Srivastava in a report issued today. However, on the same day, Investec maintained a Hold rating on Bajaj Finance Limited (NSE: BAJFINANCE).